Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. They are committed to transforming the treatment landscape for acid-related GI disorders, with a focus on a potassium-competitive acid blocker (PCAB). Phathom holds exclusive rights in the US, Europe, and Canada for their PCAB and aims to improve the lives of patients suffering from these conditions.
Registre Officiel
Analyse Qualité IA
Détails du Score de Confiance
Liens Rapides
Points forts du site
🌟 Entreprises similaires de confiance
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing oral antiviral therapies. They are dedicated to addressing unmet medical needs through innovative treatments for viral diseases. Their core focus is on the discovery, development, and commercialization of oral direct-acting antiviral therapies.
GTP BIOWAYS CDMO
OLON France est un CDMO expert au service de l'industrie biopharmaceutique. Ils offrent une large gamme de services comprenant le développement de procédés, la fabrication BPF et le développement analytique pour les produits biologiques. Leur expertise englobe la production en cellules de mammifères, les systèmes microbiens et les bioconjugués, ce qui les positionne comme un partenaire polyvalent pour le développement de médicaments.